Restrictive lung disease: Difference between revisions

Jump to navigation Jump to search
 
(43 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Infobox Disease
__NOTOC__
| Name          = {{PAGENAME}}
{{Restrictive lung disease}}
| Image          =
| Caption        =
| DiseasesDB    =
| ICD10          =
| ICD9          = {{ICD9|518.89}}
| ICDO          =
| OMIM          =
| MedlinePlus    =
| eMedicineSubj  = med
| eMedicineTopic = 2012
| MeshID        =
}}
{{SI}}
{{CMG}}


'''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; {{AE}} {{ADG}}, {{Akshun}}, {{USAMA}}, {{CZ}}
 
{{EH}}


==Overview==
==Overview==
Restrictive lung disease (RLD) is a group of diseases characterized by an inability to attain complete expansion of the lungs. This may result from an abnormality in the parenchyma of the lungs or an abnormality outside the lung parenchyma (such as fluid accumulation or [[musculoskeletal]] abnormalities) hindering normal lung expansion and thus ability to ventilate normally. Restrictive lung diseases presents with a restrictive pattern on [[pulmonary function test]] and includes a decrease in [[total lung capacity]] (TLC), [[residual volume]] (RV), [[forced vital capacity]] (FVC), forced expiatory volume (FEV1), and a normal to increased FEV1/FVC ratio. Unlike obstructive lung disease (characterized by air trapping within the lungs), restrictive lung diseases result in decreased lung volumes and a lower than normal amount of air within the lungs. RLDs include [[acute respiratory distress syndrome]], [[hypersensitivity pneumonitis]], [[occupational lung disease|occupational lung diseases]], [[pleural effusion]], [[interstitial lung disease]], [[sarcoidosis]], and neuromuscular diseases such as [[scoliosis]], [[muscular dystrophy]], [[ALS|amyotropic lateral sclerosis (ALS)]], and [[myasthenia gravis]].


'''Restrictive lung diseases''' are a category of [[respiratory disease]] characterized by a loss of [[Pulmonary compliance|lung compliance]],<ref name="emedicineRLD">{{cite web |url= http://www.emedicine.com/med/topic2012.htm|title= Restrictive Lung Disease|accessdate=2008-04-19 |author= Sharma, Sat|date= |work= |publisher=}}</ref> causing incomplete lung expansion and increased lung stiffness.
==Classification==
 
Various diseases that present with a restrictive pattern on pulmonary function tests include:
== Complete Differential Diagnosis for Restrictive Lung Disease ==  
*[[Acute respiratory distress syndrome]]
 
*[[Hypersensitivity pneumonitis]]
*[[Abestosis]]
*[[Occupational lung disease|Occupational lung diseases]]
*[[Ankylosing spondylitis]]
*[[Pleural Effusion]]
*[[Bagassosis]]
*[[Interstitial lung disease]]
*[[Berylliosis]]
*[[Sarcoidosis]]  
*[[Bird Fanciers Lung]]
*Neuromuscular diseases
*[[Dermatomyositis]]
**[[Scoliosis]]
*[[Drugs|Drug treatments]]
**[[Muscular dystrophy]]
*[[Farmers Lung]]
**[[ALS|Amyotropic lateral sclerosis (ALS)]]
*[[Fibrothorax]]
**[[Myasthenia gravis]]
*[[Hard Metal Fibrosis]]
*[[kyphosis|Idiopathic kyphosis]]
*[[Interstitial Pneumonia]]
*[[Interstitial pneumonitis]]
*[[Lymphangioleiomyomatosis]]
*[[Pleural Effusion|Massive Pleural Effusion]]
*[[Mushroom Worker Lung]]
*[[Myopathy]]
*[[Myositis]]
*[[Obesity]]
*[[neuropathy|Phrenic neuropathy]]
*[[Pneumoconiosis]]
*[[Polymyositis]]
*[[Pulmonary Vasculitis]]
*[[Rheumatoid Arthritis]]
*[[Sarcoidosis]]
*[[Scleroderma]]
*[[Silicosis]]
*[[Systemic Lupus Erythematosus]]
*[[Talc]]


==Pathophysiology==
== Spirometry Findings in Various Lung Conditions ==
[[Spirometry]] can help distinguish restrictive lung disease from [[Obstructive lung disease|obstructive lung diseases]]. On [[spirometry]] the findings include:<ref name="pmid16264058">{{cite journal |vauthors=Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J |title=Interpretative strategies for lung function tests |journal=Eur. Respir. J. |volume=26 |issue=5 |pages=948–68 |date=November 2005 |pmid=16264058 |doi=10.1183/09031936.05.00035205 |url=}}</ref><ref name="pmid25506373">{{cite journal |vauthors=Mehrparvar AH, Sakhvidi MJ, Mostaghaci M, Davari MH, Hashemi SH, Zare Z |title=Spirometry values for detecting a restrictive pattern in occupational health settings |journal=Tanaffos |volume=13 |issue=2 |pages=27–34 |date=2014 |pmid=25506373 |pmc=4260070 |doi= |url=}}</ref>


The underlying process is usually [[pulmonary fibrosis]] (scarring of the lung). As the disease progresses, the normal lung tissue is gradually replaced by scar tissue interspersed with pockets of air. This can lead to parts of the lung having a honeycomb-like appearance.
{| class="wikitable"
! align="center" style="background:#4479BA; color: #FFFFFF;" |Pulmonary Function Tests (PFT)
! align="center" style="background:#4479BA; color: #FFFFFF;" |Obstructive Lung Disease
! align="center" style="background:#4479BA; color: #FFFFFF;" |Restrictive Lung Disease
! rowspan="7" |[[image:Figure 39 03 05f.jpg|thumb|center|Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])]]
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Total lung capacity (TLC)'''
|'''↑'''
|↓
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Residual volume (RV)'''
|'''↑'''
|↓
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Forced vital capacity (FVC)'''
|↓
|↓
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Forced expiratory volume'''
'''in 1<sup>st</sup> second'''


==Causes and classification==
'''(FEV1)'''
|↓↓
|↓
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''FEV1/FVC ratio'''
|↓
|N to '''↑'''
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Maximum voluntary ventilation'''
|↓
|↓
|}


Restrictive lung diseases may be due to specific causes which can be intrinsic to the [[parenchyma]] of the lung, or extrinsic to it.<ref name="urleMedicine - Restrictive Lung Disease : Article by Sat Sharma">{{cite web |url=http://www.emedicine.com/med/topic2012.htm |title=eMedicine - Restrictive Lung Disease : Article by Sat Sharma |format= |work= |accessdate=2008-11-21}}</ref>
== Approach to Lung Disorders ==
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | A01 | | | | | | | | | |A01=Spirometry}}
{{familytree | | | | | | | | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | |}}
{{familytree | | | | | | B01 | | | | | | | | | | | | | | B02 | | | |B01=Low FEV1/FVC ratio|B02=Normal to high FEV1/FVC ratio|}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | }}
{{familytree | | | | | | C01 | | | | | | | | | | | | | | C02 | | | |C01=Obstructive Lung Disease|C02=Restrictive Lung Disease|}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | }}
{{familytree | | | | | | D01 | | | | | | | | | | | | | | D02 | | | | |D01=Bronchodilator therapy|D02=DLCO}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | }}
{{familytree | |,|-|-|-|-|^|-|-|-|-|.| | | | | |,|-|-|-|-|^|-|-|-|-|.| }}
{{familytree | E01 | | | | | | | | E02 | | | | E03 | | | | | | | | E04 | | |E01=Increased FEV1|E02=No change in FEV1|E03=Normal DLCO|E04=Decreased DLCO|}}
{{familytree | |!| | | | | | | | | |!| | | | | |!| | | | | | | | | |!| | | }}
{{familytree | F01 | | | | | | | | F02 | | | | F03 | | | | | | | | F04 | | |F01=Asthma|F02=COPD|F03=Chest wall disorders|F04=Interstitial Lung Disease|}}
{{familytree/end}}


===Intrinsic===
==Differentiating Restrictive Lung Disease from other Diseases==
 
Restrictive lung disease must be differentiated from other diseases that cause [[dyspnea]], [[cough]], [[hemoptysis]], and [[fever]] such as [[Acute respiratory distress syndrome|ARDS]], [[hypersensitivity pneumonitis]], [[pneumoconiosis]], [[sarcoidosis]], [[pleural effusion]], [[Interstitial lung disease|interstitial lung disease (ILD)]], [[lymphocytic interstitial pneumonia]], [[obesity]], [[pulmonary eosinophilia]], and [[Neuromuscular disorder|neuromuscular disorders]].
* [[Asbestosis]] caused by long-term exposure to asbestos dust.
* [[Radiation fibrosis]], usually from the radiation given for cancer treatment.
* Certain drugs such as [[amiodarone]], [[bleomycin]] and [[methotrexate]].
* As a consequence of another disease such as [[rheumatoid arthritis]].
* [[Hypersensitivity pneumonitis]] due to an allergic reaction to inhaled particles.
* [[Acute respiratory distress syndrome]] ([[ARDS]]), a severe lung condition occurring in response to a critical illness or injury.
* [[Infant respiratory distress syndrome]] due to a deficiency of [[surfactant]] in the lungs of a baby born prematurely.
 
Many cases of restrictive lung disease are [[idiopathic]] (have no known cause). Examples are:
* [[Idiopathic pulmonary fibrosis]]
* [[Idiopathic interstitial pneumonia]], of which there are several types
* [[Sarcoidosis]]
* [[Eosinophilic pneumonia]]
* [[Lymphangioleiomyomatosis]]
* Pulmonary [[Langerhans cell histiocytosis]]
* [[Pulmonary alveolar proteinosis]]
 
Conditions specifically affecting the interstitium are called [[interstitial lung disease]]s.
 
===Extrinsic===
 
[[Quadriplegia]] can be a cause of restrictive lung disease.<ref name="pmid2780083">{{cite journal |author=Walker J, Cooney M, Norton S |title=Improved pulmonary function in chronic quadriplegics after pulmonary therapy and arm ergometry |journal=Paraplegia |volume=27 |issue=4 |pages=278–83 |year=1989 |month=August |pmid=2780083 |doi= |url=}}</ref>
 
==Clinical Presentation==
 
The main symptoms are:
 
* [[Shortness of breath]]
* [[Cough]]
 
==Diagnosis==
 
In restrictive lung disease, both the [[FEV1]] and [[FVC]] are reduced so the [[FEV1/FVC ratio]] is normal or even increased in contrast to obstructive lung disease where this ratio is reduced. The values for residual volume and total lung capacity are generally decreased in restrictive lung disease<ref >{{cite web |url= http://www.spirxpert.com/characteristic6.htm |title= www.spirXpert.com |format= |work= }}</ref>.
 
One definition requires a [[total lung capacity]] which is 80% of the expected value.<ref name="pmid11991875">{{cite journal |author=Brack T, Jubran A, Tobin MJ |title=Dyspnea and decreased variability of breathing in patients with restrictive lung disease |journal=Am. J. Respir. Crit. Care Med. |volume=165 |issue=9 |pages=1260–4 |year=2002 |month=May |pmid=11991875 |doi= |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=11991875}}</ref>


<small>
{| class="wikitable"
|-
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease
! colspan="11" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PFT
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History/Exposure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dyspnea
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Cough
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hemoptysis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Cyanosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clubbing
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |JVD
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Peripheral edema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Auscultation
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other prominent findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |DLCO
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CXR
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |'''[[Acute respiratory distress syndrome|Acute Respiratory Distress Syndrome]] ([[Acute respiratory distress syndrome|ARDS]])'''<ref name="pmid23825769">{{cite journal |vauthors=Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H |title=Acute respiratory distress syndrome: new definition, current and future therapeutic options |journal=J Thorac Dis |volume=5 |issue=3 |pages=326–34 |date=June 2013 |pmid=23825769 |pmc=3698298 |doi=10.3978/j.issn.2072-1439.2013.04.05 |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Trauma]]
* [[Sepsis]]
* [[Drug overdose]]
* [[Blood transfusion|Massive transfusion]]
* [[Acute pancreatitis]]
* [[Aspiration pneumonia]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Coarse [[breath sounds]]
* [[Rhonchi]]
* Decreased [[breath sounds]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Initially [[respiratory alkalosis]] transforming to respiratory acidosis
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
* [[BNP]] level of less than 100 pg/mL
* [[Leukopenia]]
* [[Leukocytosis]]
* [[Thrombocytopenia]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bilateral pulmonary infiltrates:
** Initially patchy peripheral
** Later diffuse bilateral
* Ground glass appearance
* Frank alveolar infiltrate
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bronchial dilatation within areas of ground-glass opacification
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Hypersensitivity pneumonitis|'''Hypersensitivity Pneumonitis''']]<ref name="pmid26310038">{{cite journal |vauthors=Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, Sverzellati N, Costabel U |title=Hypersensitivity Pneumonitis: A Comprehensive Review |journal=J Investig Allergol Clin Immunol |volume=25 |issue=4 |pages=237–50; quiz follow 250 |date=2015 |pmid=26310038 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* History of [[allergen]] exposure
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Diffuse fine bibasilar [[crackles]] 
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Constitutional symptoms:
** [[Weight loss]]
** Anorexia
** Muscle weakness
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Neutrophilia]]
* Elevated [[ESR]]
* Elevated [[CRP]]
* Elevated [[immunoglobulin]]
* No peripheral blood [[eosinophilia]]<ref name="pmid12484500">{{cite journal |vauthors=Yi ES |title=Hypersensitivity pneumonitis |journal=Crit Rev Clin Lab Sci |volume=39 |issue=6 |pages=581–629 |date=November 2002 |pmid=12484500 |doi=10.1080/10408360290795583 |url=}}</ref>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Poorly defined micronodular or diffuse interstitial pattern
* In chronic form:
** Fibrosis
** Loss of lung volume
** Coarse linear opacities
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Ground–glass opacities
* Diffusely increased radiodensities
* Diffuse micronodules
* Focal air trapping
* Mosaic perfusion
* Occasionaly thin-walled cysts
* Mild fibrotic changes 
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical diagnosis
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |[[Occupational lung disease|'''Pneumoconiosis''']]<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref>
|[[Occupational lung disease|'''Silicosis''']]<ref name="pmid16545629">{{cite journal |vauthors=du Bois RM |title=Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis |journal=Clin. Chest Med. |volume=27 |issue=1 Suppl 1 |pages=S17–25, v–vi |year=2006 |pmid=16545629 |doi=10.1016/j.ccm.2005.08.001 |url=}}</ref><ref name="pmid21996929">{{cite journal |vauthors=Neghab M, Mohraz MH, Hassanzadeh J |title=Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust |journal=J Occup Health |volume=53 |issue=6 |pages=432–8 |year=2011 |pmid=21996929 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |'''Occupational history'''
* Sandblasting
* Bystanders
* Quartzite miller
* Tunnel workers
* Silica flour workers
* Workers in the scouring powder industry
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Fine [[crackles]]
*[[Rhonchi]]
*Bronchial breath sounds
*Expiratory [[wheezing]]
*Increased [[tactile fremitus]].
*Loud P2
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Increased susceptiblity to [[tuberculosis]].
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Abnormal sputum]]
*[[Anemia]]
*[[Neutrophilia]]
*Elevated [[ESR]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Small round opacities
** Symmetrically distributed
** Upper–zone predominance
* Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Nodular changes in lung parenchyma
* Progressive massive fibrosis
* Bullae, [[emphysema]]
* [[Pleural]], [[mediastinal]], and hilar changes
| rowspan="4" align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Asbestosis|'''Asbestosis''']]<ref name="pmid10949878">{{cite journal |vauthors=Billings CG, Howard P |title=Asbestos exposure, lung cancer and asbestosis |journal=Monaldi Arch Chest Dis |volume=55 |issue=2 |pages=151–6 |date=April 2000 |pmid=10949878 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Shipyard workers
* Pipe fitting
* Insulators
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Fine [[crackles]]
*[[Rhonchi]]
*Bronchial breath sounds
*Expiratory [[wheezing]]
*Increased [[tactile fremitus]].
*Loud P2
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Lung cancer]]
* [[Mesothelioma]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Abnormal sputum]]
*[[Anemia]]
*[[Neutrophilia]]
*Elevated [[ESR]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Predilection to lower lobes
* Fine and coarse linear, peripheral, reticular opacities
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Subpleural linear opacities seen parallel to the pleura
* Basilar lung fibrosis
* Peribronchiolar, intralobular, and interlobular septal fibrosis
* Honeycombing
* Pleural plaques
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Berylliosis|'''Berylliosis''']]<ref name="pmid19894178">{{cite journal |vauthors=Sood A |title=Current treatment of chronic beryllium disease |journal=J Occup Environ Hyg |volume=6 |issue=12 |pages=762–5 |date=December 2009 |pmid=19894178 |pmc=2774897 |doi=10.1080/15459620903158698 |url=}}</ref> 
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Electronic manufactures
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Fine [[crackles]]
*[[Rhonchi]]
*Bronchial breath sounds
*Expiratory [[wheezing]]
*Increased [[tactile fremitus]].
*Loud P2
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Abnormal sputum]]
*[[Anemia]]
*[[Neutrophilia]]
*Elevated [[ESR]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Hilar adenopathy
* Increased interstitial markings.
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Ground glass opacification
* Parenchymal nodules
* Septal lines
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Byssinosis|'''Byssinosis''']] <ref name="pmid8693449">{{cite journal |vauthors=McL Niven R, Pickering CA |title=Byssinosis: a review |journal=Thorax |volume=51 |issue=6 |pages=632–7 |date=June 1996 |pmid=8693449 |pmc=1090498 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Cotton wool workers
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Fine [[crackles]]
*[[Rhonchi]]
*Bronchial breath sounds
*Expiratory [[wheezing]]
*Increased [[tactile fremitus]].
*Loud P2
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased susceptibility to ''[[Actinomyces]]'' and ''[[Aspergillus]]'' infection.
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Abnormal sputum]]
*[[Anemia]]
*[[Neutrophilia]]
*Elevated [[ESR]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Diffuse air-space consolidation
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Pulmonary fibrosis]] with honeycombing
* Peri-bronchovascular distribution of nodules
* Ground-glass attenuations
|-
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease
! colspan="11" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PFT
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History/Exposure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dyspnea
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Cough
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hemoptysis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Cyanosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clubbing
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |JVD
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Peripheral edema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Auscultation
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other prominent findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |DLCO
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CXR
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |'''[[Sarcoidosis]]'''
'''(stage 2–5)'''<ref name="pmid27378039">{{cite journal |vauthors=Carmona EM, Kalra S, Ryu JH |title=Pulmonary Sarcoidosis: Diagnosis and Treatment |journal=Mayo Clin. Proc. |volume=91 |issue=7 |pages=946–54 |date=July 2016 |pmid=27378039 |doi=10.1016/j.mayocp.2016.03.004 |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* African American
* [[Autoimmune]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Usually normal
* Occasional crackles
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Dermatological lesions|Dermatologic manifestations]]
* [[Ocular]] involvement
* [[Osseous]] involvement
* [[Heart failure]] from [[cardiomyopathy]]<ref name="pmid18032765">{{cite journal |vauthors=Iannuzzi MC, Rybicki BA, Teirstein AS |title=Sarcoidosis |journal=N. Engl. J. Med. |volume=357 |issue=21 |pages=2153–65 |date=November 2007 |pmid=18032765 |doi=10.1056/NEJMra071714 |url=}}</ref>
* Lymphocytic [[meningitis]]
* [[Cranial nerve palsies]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Hypercalcemia]] or [[hypercalciuria]] 
* Elevated [[Vitamin D|1, 25–dihydroxyvitamin D levels]]
* Elevated [[angiotensin-converting enzyme|angiotensin–converting enzyme]] (ACE)
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bilateral hilar [[lymphadenopathy]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* High–resolution CT (HRCT):
** Active alveolitis
** Fibrosis
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Pleural effusion|'''Pleural Effusion''']]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |'''Transudate'''
* [[Congestive heart failure|CHF]]
* [[Cirrhosis]]
'''Exudate'''
* [[Parapneumonic effusion|Parapneumonic causes]] 
* [[Malignancy]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[tactile fremitus]] 
* Diminished or inaudible [[breath sounds]]
* Pleural [[friction rub]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Peripheral edema]], [[distended neck veins]], and S3 gallop suggests [[congestive heart failure]]
* [[Edema]] may also be a manifestation of [[nephrotic syndrome]], [[pericardial disease]], or when combined with yellow nailbeds, the [[yellow nail syndrome]].
* [[Cutaneous]] changes and [[ascites]] suggest [[Liver diseases|liver disease]].
* [[Lymphadenopathy]] or a palpable mass suggests [[malignancy]].
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thoracentesis]] 
** [[Exudate]]
** [[Transudate]]
** [[LDH]], [[glucose]], [[cytology]]
* Other specific labs of underlying etiology
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |Supine:
* Blunting of the costophrenic angle
* Homogenous increase in density spread over the lower lung fields
Lateral decubitus:
* Free flowing effusion as layers
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Thickened pleura
* Mild effusions can aslo be detected
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thoracocentesis]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Interstitial lung disease|'''Interstitial lung disease''']]<ref name="pmid15316211">{{cite journal |vauthors=Boros PW, Franczuk M, Wesolowski S |title=Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases |journal=Respiration |volume=71 |issue=4 |pages=374–9 |date=2004 |pmid=15316211 |doi=10.1159/000079642 |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Connective tissue disorder|Connective–tissue disorder]]
* [[Pneumoconiosis]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | ++
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/–
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* End–inspiratory fine [[crackles]]
* [[Wheezing]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased A-a gradient
* Normal pCO2
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |Depending on the underlying cause:
* Elevated [[ESR]]
* Serologic testing for [[ANA]], [[RF]], [[Anti-neutrophil cytoplasmic antibody|ANCA]], and ASCA may be positive
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Reticular and/or nodular opacities
* Honeycomb appearance (late finding)
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bilateral reticular and nodular interstitial infiltrates
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Video–assisted thoracoscopic lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Interstitial Pneumonia|'''Lymphocytic Interstitial Pneumonia''']]<ref name="pmid10397102">{{cite journal |vauthors=Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H |title=Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT |journal=AJR Am J Roentgenol |volume=173 |issue=1 |pages=71–4 |year=1999 |pmid=10397102 |doi=10.2214/ajr.173.1.10397102 |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Autoimmune]]
* [[Lymphoproliferative disorders]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Wheezing]]
* [[Rales]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased A–a gradient
* Normal PCO2
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Polyclonal [[hypergammaglobulinemia]]
* Increased [[LDH]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bibasilar interstitial or micronodular infiltrates
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Determines the degree of [[fibrosis]]
* Cysts (characterstic)
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Open lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Obesity|'''Obesity''']]<ref name="pmid21116339">{{cite journal |vauthors=Zammit C, Liddicoat H, Moonsie I, Makker H |title=Obesity and respiratory diseases |journal=Int J Gen Med |volume=3 |issue= |pages=335–43 |year=2010 |pmid=21116339 |pmc=2990395 |doi=10.2147/IJGM.S11926 |url=}}</ref><ref name="O’Neill2015">{{cite journal|last1=O’Neill|first1=Donal|title=Measuring obesity in the absence of a gold standard|journal=Economics & Human Biology|volume=17|year=2015|pages=116–128|issn=1570677X|doi=10.1016/j.ehb.2015.02.002}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Diabetes mellitus]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Wheezing]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Polycythemia|Increased hematocrit]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* X ray findings are often limited due to body habitus
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* CT findings are variable and depends upon severity of obesity
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Clinical
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Eosinophilia|'''Pulmonary Eosinophilia''']]<ref name="pmid19706907">{{cite journal |vauthors=de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML |title=Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma |journal=Am. J. Trop. Med. Hyg. |volume=81 |issue=3 |pages=424–7 |year=2009 |pmid=19706907 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |'''Infections'''
* [[Parasitic]]
* [[Fungal]]
* [[Mycobacterial]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Wheezing]]
* [[Rales]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased A–a gradient
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Leukocytosis]] with [[eosinophilia]] (> 250/µL)
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Interstitial or diffuse nodular densities
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Determines extent and distribution of the disease
* Interstitial infiltrates
* [[Cysts]] and nodules
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Biopsy of lesion (skin or lung)
|-
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease
! colspan="11" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PFT
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History/Exposure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dyspnea
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Cough
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hemoptysis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Cyanosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clubbing
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |JVD
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Peripheral edema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Auscultation
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other prominent findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |DLCO
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CXR
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |'''Neuromuscular diseases'''<ref name="pmid9886443">{{cite journal |vauthors=Polkey MI, Lyall RA, Moxham J, Leigh PN |title=Respiratory aspects of neurological disease |journal=J. Neurol. Neurosurg. Psychiatry |volume=66 |issue=1 |pages=5–15 |date=January 1999 |pmid=9886443 |pmc=1736177 |doi= |url=}}</ref>
|'''[[Scoliosis]]'''<ref name="pmid18724205">{{cite journal |vauthors=Bowen RE, Scaduto AA, Banuelos S |title=Decreased body mass index and restrictive lung disease in congenital thoracic scoliosis |journal=J Pediatr Orthop |volume=28 |issue=6 |pages=665–8 |date=September 2008 |pmid=18724205 |doi=10.1097/BPO.0b013e3181841ffd |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Postural abnormality
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* In severe [[scoliosis]], the rib cage may press against the lungs making it more difficult to breathe.
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* F/O genetic conditions
** [[Marfan's syndrome]]
** [[Edwards syndrome|Edward's syndrome]]
* Total [[Lymphocyte|lymphocyte count]] (should be >1500/μL)
* Nutritional status must be assessed
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* N/A
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Clinical
* Radiographs
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Muscular dystrophy|'''Muscular dystrophy''']]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Proximal muscle weakness
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Rash]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Elevated [[CPK]] and [[aldolase]]
* [[Antinuclear antibodies|+ANA]]
* +Anti–Jo abs
* Elevated [[ESR]], [[C-reactive protein|CRP]] and [[RF]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* N/A
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* N/A
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Muscle biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[ALS|'''ALS''']]<ref name="pmid9230256">{{cite journal |vauthors=Vitacca M, Clini E, Facchetti D, Pagani M, Poloni M, Porta R, Ambrosino N |title=Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis |journal=Eur. Respir. J. |volume=10 |issue=7 |pages=1614–21 |date=July 1997 |pmid=9230256 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Muscle weakness]]
* [[Neurological]] deficit
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |–
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Symptoms begin with limb involvement due to [[muscle weakness]] and [[atrophy]]. 
* [[Cognitive deficit|Cognitive]] or behavioral dysfunction
* [[Sensory nerves]] and the [[autonomic nervous system]] are generally unaffected
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*N/A
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Not significant
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Not significant
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Clinical diagnosis
* [[Nerve conduction studies]] and needle [[electromyography]] (EMG) 
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Myasthenia gravis|'''Myasthenia gravis''']]<ref name="pmid2040830">{{cite journal |vauthors=Roy TM, Walker JF, Farrow JR |title=Respiratory failure associated with myasthenia gravis |journal=J Ky Med Assoc |volume=89 |issue=4 |pages=169–73 |date=April 1991 |pmid=2040830 |doi= |url=}}</ref>
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Difficulty in:
** Getting up from chair
** Combing
** [[Dysphagia|Swallowing]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | –
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Extraocular, bulbar, or proximal limb muscles.
* Breathing is rapid and shallow
* Respiratory muscle weakness may lead to acute respiratory failure and require immediate intubation
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Anti–acetylcholine receptor (AChR) antibody (Ab) test positive
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |NL
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thymoma]] as an anterior mediastinal mass
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thymoma]] as an anterior mediastinal mass
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Electromyography]]
|}
</small>
==References==
==References==
{{reflist|2}}
{{Reflist|2}}
 
==See Also==


==Related Chapters==
* [[Chronic obstructive lung disease]]
* [[Chronic obstructive lung disease]]
* [http://www.twohealthylungs.com/ Treatments for COPD] - How to overcome any lung-related illness.
* [[Interstitial lung disease]]
 
==Additional Resources==
{{refbegin|2}}
* Baughman RP, Lower EE. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest. Oct 1992;102(4):1090-4. 
* Baydur A. Respiratory muscle strength and control of ventilation in patients with neuromuscular disease. Chest. Feb 1991;99(2):330-8. 
* Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. Jan 1998;157(1):199-203.
* Douglas WW, Ryu JH, Swensen SJ, et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. Am J Respir Crit Care Med. Jul 1998; 158(1): 220-5. 
* Fishbein MC. Diagnosis: to biopsy or not to biopsy: assessing the role of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Chest. Nov 2005;128 (5 Suppl 1): 520S-525S.
* Flaherty KR, Martinez FJ, Travis W, Lynch JP 3rd. Nonspecific interstitial pneumonia (NSIP). Semin Respir Crit Care Med. Aug 2001;22(4): 423-34.
* Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J. Feb 2002; 19(2): 275-83.
* Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med. Apr 1998;157(4 Pt 1):1063-72. 
* Goldstein RH, Fine A. Potential therapeutic initiatives for fibrogenic lung diseases. Chest. Sep 1995;108(3):848-55.
* Hunninghake GW, Kalica AR. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med. Mar 1995; 151 (3 Pt 1): 915-8. 
* Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. Apr 1998;157(4 Pt 1): 1301-15. 
* Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. Jun 21 2005;142(12 Pt 1): 963-7.
* Mathieson JR, Mayo JR, Staples CA, Muller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. Apr 1989; 171(1): 111-6. 
* Muller NL. Clinical value of high-resolution CT in chronic diffuse lung disease. AJR Am J Roentgenol. Dec 1991;157(6):1163-70. 
* Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest. Nov 2005;128(5): 3310-5.
* Peckham RM, Shorr AF, Helman DL. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration. Mar-Apr 2004;71(2): 165-9.
* Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. Jan 8 2004; 350(2): 125-33. 
* Remy-Jardin M, Remy J, Giraud F, et al. Computed tomography assessment of ground-glass opacity: semiology and significance. J Thorac Imaging. Fall 1993; 8(4): 249-64.
* Shah NR, Noble P, Jackson RM, et al. A critical assessment of treatment options for idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. Oct 2005; 22(3): 167-74.
* Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. Aug 1980;35(8): 593-9.
* Vianello A, Bevilacqua M, Salvador V, et al. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne''s muscular dystrophy. Chest. Feb 1994; 105(2): 445-8.
* Wagner JD, Stahler C, Knox S, et al. Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates. Am J Surg. Aug 1992;164(2): 104-7; discussion 108.
* Wells A. Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis. Thorax. Dec 1998;53(12):1080-7.
* Winterbauer RH, Hammar SP, Hallman KO, et al. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med. Oct 1978;65(4):661-72.
* du Bois RM. Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis. Clin Chest Med. Mar 2006;27(1 Suppl 1):S17-25, v-vi.
{{refend}}
 
 
 
 
{{Medical conditions}}
{{Medical conditions}}
{{Respiratory pathology}}
{{Respiratory pathology}}
{{SIB}}


[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 14:20, 21 March 2018

Restrictive Lung Disease Microchapters

Overview

Classification

Acute respiratory distress syndrome
Hypersensitivity pneumonitis
Occupational lung diseases
Pleural Effusion
Interstitial lung disease
Sarcoidosis
Neuromuscular diseases
Scoliosis
Muscular dystrophy
Amyotropic lateral sclerosis (ALS)
Myasthenia gravis

Spirometry Findings in Various Lung Conditions

Approach to Lung Disorders

Differentiating Restrictive Lung Disease from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2], Akshun Kalia M.B.B.S.[3], Usama Talib, BSc, MD [4], Cafer Zorkun, M.D., Ph.D. [5]

Overview

Restrictive lung disease (RLD) is a group of diseases characterized by an inability to attain complete expansion of the lungs. This may result from an abnormality in the parenchyma of the lungs or an abnormality outside the lung parenchyma (such as fluid accumulation or musculoskeletal abnormalities) hindering normal lung expansion and thus ability to ventilate normally. Restrictive lung diseases presents with a restrictive pattern on pulmonary function test and includes a decrease in total lung capacity (TLC), residual volume (RV), forced vital capacity (FVC), forced expiatory volume (FEV1), and a normal to increased FEV1/FVC ratio. Unlike obstructive lung disease (characterized by air trapping within the lungs), restrictive lung diseases result in decreased lung volumes and a lower than normal amount of air within the lungs. RLDs include acute respiratory distress syndrome, hypersensitivity pneumonitis, occupational lung diseases, pleural effusion, interstitial lung disease, sarcoidosis, and neuromuscular diseases such as scoliosis, muscular dystrophy, amyotropic lateral sclerosis (ALS), and myasthenia gravis.

Classification

Various diseases that present with a restrictive pattern on pulmonary function tests include:

Spirometry Findings in Various Lung Conditions

Spirometry can help distinguish restrictive lung disease from obstructive lung diseases. On spirometry the findings include:[1][2]

Pulmonary Function Tests (PFT) Obstructive Lung Disease Restrictive Lung Disease
Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])
Total lung capacity (TLC)
Residual volume (RV)
Forced vital capacity (FVC)
Forced expiratory volume

in 1st second

(FEV1)

↓↓
FEV1/FVC ratio N to
Maximum voluntary ventilation

Approach to Lung Disorders

 
 
 
 
 
 
 
 
 
 
 
 
 
Spirometry
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal to high FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obstructive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
Restrictive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bronchodilator therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased FEV1
 
 
 
 
 
 
 
No change in FEV1
 
 
 
Normal DLCO
 
 
 
 
 
 
 
Decreased DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asthma
 
 
 
 
 
 
 
COPD
 
 
 
Chest wall disorders
 
 
 
 
 
 
 
Interstitial Lung Disease
 
 

Differentiating Restrictive Lung Disease from other Diseases

Restrictive lung disease must be differentiated from other diseases that cause dyspnea, cough, hemoptysis, and fever such as ARDS, hypersensitivity pneumonitis, pneumoconiosis, sarcoidosis, pleural effusion, interstitial lung disease (ILD), lymphocytic interstitial pneumonia, obesity, pulmonary eosinophilia, and neuromuscular disorders.

Disease Clinical manifestations Diagnosis
History Symptoms Physical exam Lab findings PFT Imaging Gold standard
History/Exposure Dyspnea Cough Hemoptysis Fever Cyanosis Clubbing JVD Peripheral edema Auscultation Other prominent findings DLCO CXR CT
Acute Respiratory Distress Syndrome (ARDS)[3] + +/– +/– +/–
  • Bilateral pulmonary infiltrates:
    • Initially patchy peripheral
    • Later diffuse bilateral
  • Ground glass appearance
  • Frank alveolar infiltrate
  • Bronchial dilatation within areas of ground-glass opacification
  • PaO2 / FiO2 <300
Hypersensitivity Pneumonitis[4] + + + +
  • Constitutional symptoms:
  • Poorly defined micronodular or diffuse interstitial pattern
  • In chronic form:
    • Fibrosis
    • Loss of lung volume
    • Coarse linear opacities
  • Ground–glass opacities
  • Diffusely increased radiodensities
  • Diffuse micronodules
  • Focal air trapping
  • Mosaic perfusion
  • Occasionaly thin-walled cysts
  • Mild fibrotic changes 
  • Clinical diagnosis
Pneumoconiosis[6] Silicosis[7][8] Occupational history
  • Sandblasting
  • Bystanders
  • Quartzite miller
  • Tunnel workers
  • Silica flour workers
  • Workers in the scouring powder industry
+ + +/– + + +
  • Small round opacities
    • Symmetrically distributed
    • Upper–zone predominance
  • Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
  • Lung biopsy
Asbestosis[9]
  • Shipyard workers
  • Pipe fitting
  • Insulators
+ + +/– + + +
  • Predilection to lower lobes
  • Fine and coarse linear, peripheral, reticular opacities
  • Subpleural linear opacities seen parallel to the pleura
  • Basilar lung fibrosis
  • Peribronchiolar, intralobular, and interlobular septal fibrosis
  • Honeycombing
  • Pleural plaques
Berylliosis[10] 
  • Electronic manufactures
+ + +/– + + +
  • Hilar adenopathy
  • Increased interstitial markings.
  • Ground glass opacification
  • Parenchymal nodules
  • Septal lines
Byssinosis [11]
  • Cotton wool workers
+ + +/– + + +
  • Diffuse air-space consolidation
  • Pulmonary fibrosis with honeycombing
  • Peri-bronchovascular distribution of nodules
  • Ground-glass attenuations
Disease Clinical manifestations Diagnosis
History Symptoms Physical exam Lab findings PFT Imaging Gold standard
History/Exposure Dyspnea Cough Hemoptysis Fever Cyanosis Clubbing JVD Peripheral edema Auscultation Other prominent findings DLCO CXR CT
Sarcoidosis

(stage 2–5)[12]

+ + + +
  • Usually normal
  • Occasional crackles
  • High–resolution CT (HRCT):
    • Active alveolitis
    • Fibrosis
Pleural Effusion Transudate

Exudate

+ + +/– +/– +/– +/– +/– +/– NL Supine:
  • Blunting of the costophrenic angle
  • Homogenous increase in density spread over the lower lung fields

Lateral decubitus:

  • Free flowing effusion as layers
  • Thickened pleura
  • Mild effusions can aslo be detected
Interstitial lung disease[14] ++ + + +/– +/– +/– +/–
  • Increased A-a gradient
  • Normal pCO2
Depending on the underlying cause:
  • Elevated ESR
  • Serologic testing for ANA, RF, ANCA, and ASCA may be positive
  •  Reticular and/or nodular opacities
  • Honeycomb appearance (late finding)
  • Bilateral reticular and nodular interstitial infiltrates
  • Video–assisted thoracoscopic lung biopsy
Lymphocytic Interstitial Pneumonia[15] + + + + +
  • Increased A–a gradient
  • Normal PCO2
NL
  • Bibasilar interstitial or micronodular infiltrates
  • Determines the degree of fibrosis
  • Cysts (characterstic)
  • Open lung biopsy
Obesity[16][17] + + + NL
  • X ray findings are often limited due to body habitus
  • CT findings are variable and depends upon severity of obesity
  • Clinical
Pulmonary Eosinophilia[18] Infections + + + + + + +
  • Increased A–a gradient
  • Interstitial or diffuse nodular densities
  • Determines extent and distribution of the disease
  • Interstitial infiltrates
  • Cysts and nodules
  • Biopsy of lesion (skin or lung)
Disease Clinical manifestations Diagnosis
History Symptoms Physical exam Lab findings PFT Imaging Gold standard
History/Exposure Dyspnea Cough Hemoptysis Fever Cyanosis Clubbing JVD Peripheral edema Auscultation Other prominent findings DLCO CXR CT
Neuromuscular diseases[19] Scoliosis[20]
  • Postural abnormality
+
  • In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
NL
  • Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
  • N/A
  • Clinical
  • Radiographs
Muscular dystrophy
  • Proximal muscle weakness
+ NL
  • N/A
  • N/A
ALS[21] +
  • N/A
NL
  • Not significant
  • Not significant
Myasthenia gravis[22]
  • Difficulty in:
+ +
  • Extraocular, bulbar, or proximal limb muscles.
  • Breathing is rapid and shallow
  • Respiratory muscle weakness may lead to acute respiratory failure and require immediate intubation
  • Anti–acetylcholine receptor (AChR) antibody (Ab) test positive
NL
  • Thymoma as an anterior mediastinal mass
  • Thymoma as an anterior mediastinal mass

References

  1. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J (November 2005). "Interpretative strategies for lung function tests". Eur. Respir. J. 26 (5): 948–68. doi:10.1183/09031936.05.00035205. PMID 16264058.
  2. Mehrparvar AH, Sakhvidi MJ, Mostaghaci M, Davari MH, Hashemi SH, Zare Z (2014). "Spirometry values for detecting a restrictive pattern in occupational health settings". Tanaffos. 13 (2): 27–34. PMC 4260070. PMID 25506373.
  3. Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H (June 2013). "Acute respiratory distress syndrome: new definition, current and future therapeutic options". J Thorac Dis. 5 (3): 326–34. doi:10.3978/j.issn.2072-1439.2013.04.05. PMC 3698298. PMID 23825769.
  4. Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, Sverzellati N, Costabel U (2015). "Hypersensitivity Pneumonitis: A Comprehensive Review". J Investig Allergol Clin Immunol. 25 (4): 237–50, quiz follow 250. PMID 26310038.
  5. Yi ES (November 2002). "Hypersensitivity pneumonitis". Crit Rev Clin Lab Sci. 39 (6): 581–629. doi:10.1080/10408360290795583. PMID 12484500.
  6. Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ (1998). "Idiopathic pulmonary fibrosis: predicting response to therapy and survival". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1063–72. doi:10.1164/ajrccm.157.4.9703022. PMID 9563720.
  7. du Bois RM (2006). "Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis". Clin. Chest Med. 27 (1 Suppl 1): S17–25, v–vi. doi:10.1016/j.ccm.2005.08.001. PMID 16545629.
  8. Neghab M, Mohraz MH, Hassanzadeh J (2011). "Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust". J Occup Health. 53 (6): 432–8. PMID 21996929.
  9. Billings CG, Howard P (April 2000). "Asbestos exposure, lung cancer and asbestosis". Monaldi Arch Chest Dis. 55 (2): 151–6. PMID 10949878.
  10. Sood A (December 2009). "Current treatment of chronic beryllium disease". J Occup Environ Hyg. 6 (12): 762–5. doi:10.1080/15459620903158698. PMC 2774897. PMID 19894178.
  11. McL Niven R, Pickering CA (June 1996). "Byssinosis: a review". Thorax. 51 (6): 632–7. PMC 1090498. PMID 8693449.
  12. Carmona EM, Kalra S, Ryu JH (July 2016). "Pulmonary Sarcoidosis: Diagnosis and Treatment". Mayo Clin. Proc. 91 (7): 946–54. doi:10.1016/j.mayocp.2016.03.004. PMID 27378039.
  13. Iannuzzi MC, Rybicki BA, Teirstein AS (November 2007). "Sarcoidosis". N. Engl. J. Med. 357 (21): 2153–65. doi:10.1056/NEJMra071714. PMID 18032765.
  14. Boros PW, Franczuk M, Wesolowski S (2004). "Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases". Respiration. 71 (4): 374–9. doi:10.1159/000079642. PMID 15316211.
  15. Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H (1999). "Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT". AJR Am J Roentgenol. 173 (1): 71–4. doi:10.2214/ajr.173.1.10397102. PMID 10397102.
  16. Zammit C, Liddicoat H, Moonsie I, Makker H (2010). "Obesity and respiratory diseases". Int J Gen Med. 3: 335–43. doi:10.2147/IJGM.S11926. PMC 2990395. PMID 21116339.
  17. O’Neill, Donal (2015). "Measuring obesity in the absence of a gold standard". Economics & Human Biology. 17: 116–128. doi:10.1016/j.ehb.2015.02.002. ISSN 1570-677X.
  18. de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML (2009). "Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma". Am. J. Trop. Med. Hyg. 81 (3): 424–7. PMID 19706907.
  19. Polkey MI, Lyall RA, Moxham J, Leigh PN (January 1999). "Respiratory aspects of neurological disease". J. Neurol. Neurosurg. Psychiatry. 66 (1): 5–15. PMC 1736177. PMID 9886443.
  20. Bowen RE, Scaduto AA, Banuelos S (September 2008). "Decreased body mass index and restrictive lung disease in congenital thoracic scoliosis". J Pediatr Orthop. 28 (6): 665–8. doi:10.1097/BPO.0b013e3181841ffd. PMID 18724205.
  21. Vitacca M, Clini E, Facchetti D, Pagani M, Poloni M, Porta R, Ambrosino N (July 1997). "Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis". Eur. Respir. J. 10 (7): 1614–21. PMID 9230256.
  22. Roy TM, Walker JF, Farrow JR (April 1991). "Respiratory failure associated with myasthenia gravis". J Ky Med Assoc. 89 (4): 169–73. PMID 2040830.

Related Chapters

Template:Medical conditions Template:Respiratory pathology

Template:WH Template:WS